Key Points
- Adlai Nortye CFO Xiaofeng Ye sold 5,667 shares at an average price of $14.25, generating $80,754.75. The sale was made to cover tax withholding tied to vested equity awards, reducing his direct ownership by 3.69% to 147,757 shares.
- ANL shares opened at $15.06 after rising 9.6%, with the stock trading between a 52-week low of $0.88 and high of $17.25. Institutional investors own 35.21% of the company.
- Analyst sentiment is mostly positive: five analysts rate the stock Buy, one rates it Sell, and the consensus is Moderate Buy with an average price target of $24.25.
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) CFO Xiaofeng Ye sold 5,667 shares of Adlai Nortye stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $14.25, for a total transaction of $80,754.75. Following the transaction, the chief financial officer directly owned 147,757 shares in the company, valued at $2,105,537.25. This represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Xiaofeng Ye also recently made the following trade(s):
- On Monday, August 24th, Xiaofeng Ye sold 6,000 shares of Adlai Nortye stock. The shares were sold at an average price of $13.98, for a total transaction of $83,880.00.
Adlai Nortye Stock Up 9.6%
ANL opened at $15.06 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.55 and a quick ratio of 0.65. The company's 50-day moving average is $12.00 and its 200 day moving average is $11.16. Adlai Nortye Ltd. Sponsored ADR has a fifty-two week low of $0.88 and a fifty-two week high of $17.25.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of ANL. SmartHarvest Portfolios LLC increased its stake in shares of Adlai Nortye by 8.5% during the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company's stock worth $113,000 after purchasing an additional 1,279 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Adlai Nortye in the 1st quarter worth approximately $457,000. ADAR1 Capital Management LLC purchased a new position in Adlai Nortye in the first quarter valued at approximately $816,000. Affinity Asset Advisors LLC purchased a new position in Adlai Nortye in the first quarter valued at approximately $1,140,000. Finally, Seven Fleet Capital Management LP bought a new position in Adlai Nortye during the second quarter valued at $1,302,000. 35.21% of the stock is owned by institutional investors.
Analysts Set New Price Targets
ANL has been the topic of several recent analyst reports. Wall Street Zen raised shares of Adlai Nortye from a "hold" rating to a "buy" rating in a research report on Saturday, August 22nd. JonesTrading started coverage on Adlai Nortye in a report on Thursday, May 14th. They issued a "buy" rating and a $22.00 target price for the company. Cantor Fitzgerald began coverage on Adlai Nortye in a research report on Monday, June 22nd. They set an "overweight" rating for the company. Oppenheimer initiated coverage on Adlai Nortye in a report on Thursday, May 28th. They set an "outperform" rating and a $32.00 price target on the stock. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Adlai Nortye in a research report on Tuesday, July 14th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $24.25.
Get Our Latest Research Report on Adlai Nortye
About Adlai Nortye
(
Get Free Report)
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
